Exousia Bio (LMMY) Equity Ratio (2022 - 2025)

Exousia Bio has disclosed Equity Ratio across 4 years of filings, most recently posting 0.99 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.99, down 1.18% year-over-year; the trailing twelve-month figure through Nov 2025 was 0.99 (down 1.18% YoY), and the FY2024 annual result was 2.0, down 154.65% from the prior year.
• Equity Ratio came in at 0.99 for Q4 2025 at Exousia Bio, down from 1.0 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 1.0 in Q4 2024 to a low of 2.1 in Q3 2024.
• The 4-year median for Equity Ratio is 1.16 (2023), against an average of 0.87.
• Across the five-year window, Equity Ratio tumbled 9602.33% in 2023 and jumped 159.66% in 2024, its largest moves.
• Exousia Bio's Equity Ratio stood at 0.01 in 2022, then slumped by 20609.88% to 1.68 in 2023, then jumped by 159.66% to 1.0 in 2024, then decreased by 1.18% to 0.99 in 2025.
• The last three Equity Ratio figures came in at 0.99 (Q4 2025), 1.0 (Q4 2024), and 2.1 (Q3 2024), per Business Quant data.